ARTHD
Arch Therapeutics Inc

8
Loading...
Loading...
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Sector:
Distribution Services
Industry:
Medical Distributors
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Arch Therapeutics Inc?
What is the 52-week high for Arch Therapeutics Inc?
What is the 52-week low for Arch Therapeutics Inc?
What is Arch Therapeutics Inc stock price today?
What was Arch Therapeutics Inc stock price yesterday?
What is the PE ratio of Arch Therapeutics Inc?
What is the Price-to-Book ratio of Arch Therapeutics Inc?
What is the 50-day moving average of Arch Therapeutics Inc?

Latest ARTHD News

View
No ARTHD news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.